Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice.
暂无分享,去创建一个
M. Nilforoushzadeh | A. Siadat | L. Shirani-Bidabadi | S. Saberi | M. Mahmoudi | A. Zolfaghari-Baghbaderani
[1] M. Nilforoushzadeh,et al. Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis , 2007, BMC complementary and alternative medicine.
[2] S. Ignacimuthu,et al. Antimicrobial activity of some ethnomedicinal plants used by Paliyar tribe from Tamil Nadu, India , 2006, BMC complementary and alternative medicine.
[3] S. Silici,et al. Chemical composition and antibacterial activity of propolis collected by three different races of honeybees in the same region. , 2005, Journal of ethnopharmacology.
[4] V. Cardile,et al. Resveratrol and propolis as necrosis or apoptosis inducers in human prostate carcinoma cells. , 2004, Oncology research.
[5] T. Baldwin,et al. The Site ofLeishmania major Infection Determines Disease Severity andImmuneResponses , 2003, Infection and Immunity.
[6] J. M. Sforcin,et al. ABSENCE OF SEASONAL EFFECT ON THE IMMUNOMODULATORY ACTION OF BRAZILIAN PROPOLIS ON NATURAL KILLER ACTIVITY , 2002 .
[7] M. Panjehshahin,et al. A double‐blind randomized clinical trial of a topical herbal extract (Z‐HE) vs. systemic meglumine antimoniate for the treatment of cutaneous leishmaniasis in Iran , 1999, International journal of dermatology.
[8] Y. Barenholz,et al. Topical amphotericin B for cutaneous leishmaniasis. , 1999, Archives of dermatology.
[9] R. Reithinger. Control of leishmaniasis. , 1999, The Veterinary record.
[10] Y. Dowlati. Cutaneous leishmaniasis: clinical aspect. , 1996, Clinics in dermatology.
[11] C. Hunter,et al. Transforming growth factor‐β inhibits interleukin‐12‐induced production of interferon‐γ by natural killer cells: A role for transforming growth factor‐β in the regulation of T cell‐independent resistance to Toxoplasma gondii , 1995 .
[12] M. Iwu,et al. Medicinal plants in the fight against leishmaniasis. , 1994, Parasitology today.
[13] P. Gayral,et al. In Vitro and In Vivo leishmanicidal activities of natural and synthetic quinoids , 1993 .
[14] V. Muñoz,et al. Effect of natural naphthoquinones in BALB/c mice infected with Leishmania amazonensis and L. venezuelensis. , 1992, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.
[15] J. Phillipson,et al. Natural products and the development of selective antiprotozoal drugs , 1990 .
[16] J. Grange,et al. Antibacterial Properties of Propolis (Bee Glue) , 1990, Journal of the Royal Society of Medicine.
[17] Rakcheev Ap,et al. The successful treatment of cutaneous leishmaniasis with an argon laser , 1989 .
[18] R. Kubba,et al. Cryosurgery in old world cutaneous leishmaniasis , 1988, The British journal of dermatology.
[19] Abdue Jabbar,et al. Treatment of Cutaneous Leishmaniasis with Infrared Heat , 1986, International journal of dermatology.
[20] M. Currie. Treatment of cutaneous leishmaniasis by curettage. , 1983, British medical journal.
[21] M. Moskwa,et al. Biological properties and clinical application of propolis. II. Studies on the antiprotozoan activity of ethanol extract of propolis. , 1977, Arzneimittel-Forschung.